Observational study to compare the clinical efficacy of the natural surfactants Alveofact and Curosurf in the treatment of respiratory distress syndrome in premature infants

Respiratory Medicine

Volumn 101, Issue 1, 2007, Pages 169-176

  Proquitté, Hans ^a   Dushe, Thekla ^a   Hammer, Hannes ^a   Rüdiger, Mario ^a   Schmalisch, Gerd ^a   Wauer, Roland R ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Gas exchange; Outcome; Premature infant; Respiratory distress syndrome; Surfactant

Indexed keywords

BERACTANT; PORACTANT;

ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN SATURATION; ARTERIAL OXYGEN TENSION; ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GAS EXCHANGE; GESTATIONAL AGE; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PNEUMOTHORAX; POSTNATAL CARE; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION;

BIOLOGICAL PRODUCTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; LENGTH OF STAY; LIPIDS; LUNG; OXYGEN INHALATION THERAPY; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; PULMONARY GAS EXCHANGE; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISCOSITY;

EID: 33845223912     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.03.033     Document Type: Article

References (35)

1. Soll R.F., and Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev (2001) CD000144
2. Clark R.H., Auten R.L., and Peabody J. A comparison of the outcomes of neonates treated with two different natural surfactants. J Pediatr 139 (2001) 828-831
3. Baroutis G., Kaleyias J., Liarou T., Papathoma E., Hatzistamatiou Z., and Costalos C. Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr 162 (2003) 476-480
4. Gortner L. Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update. J Perinat Med 20 (1992) 409-419
5. Ikegami M., and Jobe A.H. Injury responses to different surfactants in ventilated premature lamb lungs. Pediatr Res 51 (2002) 689-695
6. Cummings J.J., Holm B.A., Hudak M.L., Hudak B.B., Ferguson W.H., and Egan E.A. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis 145 (1992) 999-1004
7. Scarpelli E.M., David E., Cordova M., and Mautone A.J. Surface tension of therapeutic surfactants (exosurf neonatal, infasurf, and survanta) as evaluated by standard methods and criteria. Am J Perinatol 9 (1992) 414-419
8. Nohara K., Berggren P., Curstedt T., Grossmann G., Nilsson R., and Robertson B. Correlations between physical and physiological properties of various preparations of lung surfactant. Eur J Respir Dis 69 (1986) 321-335
9. Ikegami M., Agata Y., Elkady T., Hallman M., Berry D., and Jobe A. Comparison of four surfactants: in vitro surface properties and responses of preterm lambs to treatment at birth. Pediatrics 79 (1987) 38-46
10. Lachmann B., Grossman G., Nilsson R., and Robertson B. Effect of supplementary surfactant on in vivo lung mechanics in the premature rabbit neonate. Eur J Pediatr 136 (1981) 173-179
11. Shalwitz R.A. Comparison of treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr 163 (2004) 126-128
12. Ramanathan R., Rasmussen M.R., Gerstmann D.R., Finer N., and Sekar K. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol 21 (2004) 109-119
13. Dinger J., Topfer A., Schaller P., and Schwarze R. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome. Eur J Pediatr 161 (2002) 485-490
14. Gortner L., Bartmann P., Pohlandt F., Bernsau U., Porz F., Hellwege H.H., et al. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial. Pediatr Pulmonol 14 (1992) 4-9
15. Gortner L., Wauer R.R., Hammer H., Stock G.J., Heitmann F., Reiter H.L., et al. Early versus late surfactant treatment in preterm infants of 27-32 weeks' gestational age: a multicenter controlled clinical trial. Pediatrics 102 (1998) 1153-1160
16. Lamboley-Gilmert G., and Lacaze-Masmonteil T. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study. Paediatr Drugs 5 (2003) 639-645
17. Rudiger M., Tolle A., Meier W., and Rustow B. Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity. Am J Physiol Lung Cell Mol Physiol 288 (2005) L379-L383
18. Rudiger M., von Baehr A., Haupt R., Wauer R.R., and Rustow B. Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often. Crit Care Med 28 (2000) 1572-1577
19. Soll R.F. Appropriate surfactant usage in 1996. Eur J Pediatr 155 (1996) 8-13
20. Hack M., Horbar J.D., Malloy M.H., Tyson J.E., Wright E., and Wright L. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network. Pediatrics 87 (1991) 587-597
21. Jobe A.H., and Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163 (2001) 1723-1729
22. Guthrie S.O., Gordon P.V., Thomas V., Thorp J.A., Peabody J., and Clark R.H. Necrotizing enterocolitis among neonates in the United States. J Perinatol 23 (2003) 278-285
23. Cotton R.B. The relationship of symptomatic patent ductus arteriosus to respiratory distress in premature newborn infants. Clin Perinatol 14 (1987) 621-633
24. Bejar R., Curbelo V., Coen R.W., Leopold G., James H., and Gluck L. Diagnosis and follow-up of intraventricular and intracerebral hemorrhages by ultrasound studies of infant's brain through the fontanelles and sutures. Pediatrics 66 (1980) 661-673
25. Blumenthal I. Periventricular leucomalacia: a review. Eur J Pediatr 163 (2004) 435-442
26. Soll R.F., Horbar J.D., Griscom N.T., Barth R.A., Lucey J.F., and Taeusch H.W. Radiographic findings associated with surfactant treatment. Am J Perinatol 8 (1991) 114-118
27. Egberts J., de Winter J.P., Sedin G., de Kleine M.J., Broberger U., van Bel F., et al. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial. Pediatrics 92 (1993) 768-774
28. Yalaz M., Arslanoglu S., Akisu M., Atik T., Ergun O., and Kultursay N. A comparison of efficacy between two natural exogenous surfactant preparations in premature infants with respiratory distress syndrome. Klin Padiatr 216 (2004) 230-235
29. Wauer R.R. The use of natural surfactant. Surfactant therapy: basic principles, diagnosis, therapy (1998), Thieme, Stuttgart, New York p. 160-2
30. Yost C.C., and Soll R.F. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev (2000) CD001456
31. Bjorklund L.J., Ingimarsson J., Curstedt T., John J., Robertson B., Werner O., et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res 42 (1997) 348-355
32. Bjorklund L.J., and Werner O. Should we do lung recruitment maneuvers when giving surfactant?. Pediatr Res 50 (2001) 6-7
33. Bjorklund L.J., Ingimarsson J., Curstedt T., Larsson A., Robertson B., and Werner O. Lung recruitment at birth does not improve lung function in immature lambs receiving surfactant. Acta Anaesthesiol Scand 45 (2001) 986-993
34. Malloy C.A., Nicoski P., and Muraskas J.K. A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome. Acta Paediatr 94 (2005) 779-784
35. Moya F.R., Gadzinowski J., Bancalari E., Salinas V., Kopelman B., Bancalari A., et al. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics 115 (2005) 1018-1029